Patients with heart failure often have a dismal prognosis ... The trial – run by Boehringer Ingelheim and Yale University – will test a smart bathroom scale device that has cardiac monitoring ...
Boehringer Ingelheim and Eli Lilly have the results they were hoping for in a large-scale study of Jardiance therapy in heart failure with preserved ejection fraction (HFpEF), a form of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback